Dopesick (2021): 1x4
Pseudo-Addiction
What’s your Reaction?
Sky-high OxyContin sales are threatened by reports of abuse, prosecutors investigate a claim central to OxyContin marketing, and Finnix begins to question the safety of the drug.
- 1 - 1First Bottle 13. Oct, 2021
- 1 - 2Breakthrough Pain 13. Oct, 2021
- 1 - 3The 5th Vital Sign 13. Oct, 2021
- 1 - 4Pseudo-Addiction 20. Oct, 2021
- 1 - 5The Whistleblower 27. Oct, 2021
- 1 - 6Hammer the Abusers 03. Nov, 2021
- 1 - 7Black Box Warning 10. Nov, 2021
- 1 - 8The People vs. Purdue Pharma 17. Nov, 2021
Subscribe
0 Comments
Most Voted